Skip to content

To study the effects of two acid-reducing medicines , Vonoprazan and Pantoprazole in people with diabetes undergoing planned surgery.

Effect of oral vonoprazan versus pantoprazole on gastric fluid properties in diabetic patients undergoing elective surgeries. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092327
Enrollment
64
Registered
2025-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: gastric pH and gastric ultrasound: not available Intervention2: gastric pH and gastric ultrasound: Vonoprazan 20mg or Pantoprazole 40mg will be administered orally night before the surg

Sponsors

Department of Anaesthesia and Intensive Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with Type 2 Diabetes Mellitus. ASA physical status one to three Scheduled for elective surgeries under general anaesthesia.

Exclusion criteria

Exclusion criteria: History of gastrointestinal surgery. Known acid-peptic disorders or gastric motility disorders. Use of acid-suppressive therapy within 72 hours prior to surgery. Pregnancy or lactation. Obesity (BMI more than 35 kg per metre square) Known renal or hepatic dysfunction. Allergy to study drugs Patients already on PPI

Design outcomes

Primary

MeasureTime frame
The pH of gastric content will be recorded using pH meter in both the groups.Timepoint: Patients will be transferred to the post-anaesthesia care unit (PACU), where they will be monitored for the incidence of postoperative nausea and vomiting (PONV) at 1 hour, 6 hours, and 24 hours postoperatively.

Secondary

MeasureTime frame
To compare the gastric residual volume in both the study groups. To evaluate any drug-related adverse events of Vonoprazan & Pantoprazole. To study the incidence of postoperative nausea & vomiting upto 24 hours in the post- operative period.Timepoint: Patients will be transferred to the post-anaesthesia care unit (PACU), where they will be monitored for the incidence of postoperative nausea & vomiting (PONV) at 1 hour, 6 hours, and 24 hours postoperatively.

Countries

India

Contacts

Public ContactDr Richa Saroa

Government Medical College and Hospital 32 Chandigarh

sanjeev_palta@yahoo.com9646121523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026